Eden lands at #13 on our women's ranking with a Luna Fit Score of 88/100 — what we found reviewing Eden goes through the six factors behind that number. If it isn't the right fit, here are the strongest alternatives for women's GLP-1 care — scored on the same women's-health rubric of PCOS suitability, clinical oversight, price, access, support and fair cancellation.
Our #1 pick for women
Luna Fit
93/100
Ranked #1 · Grade A
CoreAge Rx
The most reliable on-ramp for women: nationwide access to both molecules at one flat, no-surprise price — including tirzepatide, the option many women with insulin resistance want.
That is 5 points above Eden on the Luna Fit Score (93 to 88). Price, coverage and every factor are set out side by side in the Eden–CoreAge Rx head-to-head.
A tiered compounded program that lays every price on the table — semaglutide, tirzepatide, a microdose lane, and a combo option — with six-month metabolic lab testing and an NAD+ adjacency that speaks to women thinking about metabolism as a whole system.
Both molecules at prices you can see up front, wrapped in a wider menu — NAD+, microdosing, and an optional coaching-and-labs bundle — for a woman who wants weight care and energy alongside it.
Among the lowest verified prices we log — compounded semaglutide and tirzepatide on a single membership, shipped nationwide. A budget-first on-ramp for women who want tirzepatide access without paying a premium.
A compounded program sold as one-off packages rather than a subscription, in Spanish as well as English, charging $200/mo for semaglutide and $250 for tirzepatide at one flat rate per dose — but its own pages give nine different starting figures, none carrying a term and none of them the price it actually charges, plus two different answers on how many states it serves.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Scores are our editorial judgment per the methodology. Not medical advice; see our disclosure.